RxDoctor Payments Data

Truptesh Kothari, MD

Gastroenterology · Rochester, NYNPI 1811159338

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (52.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Olympus Corporation Of The Americas at 48.9% of the total. Reporting peaked in 2019 at $13,259 and has fallen 95.2% since, to $631 in 2025.

$22,147in general payments, 2019–2025

Across 51 payments — averaging $434.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$11K
  • Medtronic$4K
  • Boston Scientific$3K
  • Covidien LP$2K
  • US Endoscopy$1K
  • Wilson Cook Medical Incorporated$1K
  • plus $1K from 6 others

What the payments were for

  • Consulting fees$1,0005%
  • Speaking & faculty fees$6,82531%
  • Travel & lodging$1,0525%
  • Food & beverage$1,5847%
  • Education$11,68653%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,147 in reported general payments places this provider in the 85th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Medicare billing

Part B allowed, 2024
$38,261
Medicare patients
132
Services billed
264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole12$201

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Rochester

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →